Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07968101000 Ext: 1 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
The income tax demand arose on account of National Faceless Assessment Center (NFAC) not granting credit of advance taxes and foreign tax credit aggregating Rs 451.49 crore and inadvertently adjusting refund of Rs 16.98 crore.
The balance demand of Rs 8.81 crore relates to disallowance pertaining to recurring issues.
There shall be no material impact on the financials/operations of the company, as the demand is factually incorrect and is not tenable in law, stated the durg major.
The pharma company added that it will file rectification application with tax authority and appeal before the appellate authority in this matter.
Mumbai-based Lupin is an innovation-led transnational pharmaceutical company. It develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe and Middle East regions.
The pharmaceutical company reported consolidated net profit of Rs 613.12 crore in Q3 FY24, steeply higher than Rs 153.47 crore posted in Q3 FY23. Revenue from operations increased 19.67% YoY to Rs 5,079.88 crore in the quarter ended 31 December 2023.
The scrip fell 0.87% to Rs 1,598.55 on the BSE.
Powered by Capital Market - Live News